Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications
Clinical Trial Grant
Duke Scholars
Principal Investigator
John Strickler
Medicine, Medical Oncology
Awarded By
AbbVie Inc.
Start Date
October 3, 2023
End Date
October 2, 2026
Awarded By
AbbVie Inc.
Start Date
October 3, 2023
End Date
October 2, 2026
